Federal contract award

75N94020F00001

TASK ORDER NO. 75N94020F00001 TITLE: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS"

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NICHD
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N94018D00007
Set-asideNot reported
Pricing typeCOST NO FEE
Obligations$315.6K
Current contract value$315.6K
Potential contract value / ceiling$315.6K
Start dateSep 24, 2020
Current end dateSep 23, 2022
Potential end dateSep 23, 2022
Latest award activityAug 24, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 24, 2026P00004$-53.6KNICHD: R&D: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS: SEVERABLE
Jun 1, 2026P00003$191NICHD: R&D: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS: SEVERABLE
Sep 29, 2025P00002$-30.9KNICHD: R&D: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS: SEVERABLE
Sep 2, 2021P00001$198.6KTASK ORDER NO. 75N94020F00001 (TO5) TITLE: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS"
Sep 23, 20200$201.4KTASK ORDER NO. 75N94020F00001 TITLE: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS"

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.